NVAX

NOVAVAX INC

Healthcare | Small Cap

-$0.25

EPS Forecast

$68.32

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.25

Revenue Forecast:

$68.32

EPS Surprise Forecast:

$0.060

Revenue Surprise Forecast:

$13

Post-release price volatility - Very high

Post-release Overnight Move:

±10.6%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

70%

Probability of beating revenue consensus:

74%

Probability of beating both EPS & revs consensus:

56%

Probability of missing both EPS & revs consensus:

12%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.27

Revenue standard deviation:

$48

As % of share price:

2.80% EXTREME UNCERTAINTY

As % of market cap:

3.04% VERY HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$0.09

Revenue 95th %ile:

$128

EPS 75th %ile:

-$0.16

Revenue 75th %ile:

$84

EPS 25th %ile:

-$0.33

Revenue 25th %ile:

$55

EPS 5th %ile:

-$0.57

Revenue 5th %ile:

$17

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

35% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$18

Bid-ask per Share:

$0.02